CSL · 19 hours ago
Senior Global Program Director
Americas, US-PA, King of Prussia, CSL Behring
Full-time
Onsite
Lead/Staff, Director/Executive
5+ years expCSL Behring is a global biotherapeutics leader driven by our promise to save lives. The Senior Global Program Director is responsible for medical oversight of selected pipeline and products, ensuring alignment with medical standards and stakeholder expectations while setting technical medical strategies for global projects.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Global responsibility for medical oversight of selected pipeline and/or products within the assigned therapeutic area(s)
Ensures medical standards and processes are in alignment with expectations of manufacturers by internal and external stakeholders including regulators, governmental agencies, payors, physicians, patients and the general public
Serves as a senior medical representative on the cross-functional therapeutic area, development teams and/or post-marketing product teams
Responsible for setting technical medical strategies for global projects and therapeutic areas, consistent with functional expectations
Identifies potential challenges, risks and roadblocks associated with the global medical strategy and works as a leader in developing solutions to address these, working cross-functionally and inter functionally with other departments
Identifies resources and tools necessary to facilitate risks and to implement necessary risk management initiatives
Interfaces with key high-level internal and external stakeholders, contributes to, and approves regulatory reports / submissions / queries
Qualification
Required
Minimum of MD (Medical Doctor degree) or international equivalent plus accredited residency
Two (2) years minimum experience as a physician in patient care
5 + years pharmaceutical / biotechnology industry experience, with 2 of which include accountability for medical oversight/evaluation or clinical development
Industry experience in designated therapeutic area(s)
Experience and success in addressing and managing complex medical issues in the pre-approval and post-approval environment
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase